Patient Preferences for Use of Archived Biospecimens from Oncology Trials When Adequacy of Informed Consent Is Unclear
- PMID: 31492767
- PMCID: PMC6964122
- DOI: 10.1634/theoncologist.2019-0365
Patient Preferences for Use of Archived Biospecimens from Oncology Trials When Adequacy of Informed Consent Is Unclear
Abstract
Background: Oncology research increasingly involves biospecimen collection and data sharing. Ethical challenges emerge when researchers seek to use archived biospecimens for purposes that were not well defined in the original informed consent document (ICD). We sought to inform ongoing policy debates by assessing patient views on these issues.
Materials and methods: We administered a cross-sectional self-administered survey to patients with cancer at an academic medical center. Survey questions addressed attitudes toward cancer research, willingness to donate biospecimens, expectations regarding use of biospecimens, and preferences regarding specific ethical dilemmas.
Results: Among 240 participants (response rate 69%), virtually all (94%) indicated willingness to donate tissue for research. Most participants (86%) expected that donated tissue would be used for any research deemed scientifically important, and virtually all (94%) expected that the privacy of their health information would be protected. Broad use of stored biospecimens and data sharing with other researchers increased willingness to donate tissue. For three scenarios in which specific consent for proposed biobank research was unclear within the ICD, a majority of patient's favored allowing the research to proceed: 76% to study a different cancer, 88% to study both inherited (germline) and tumor specific (somatic) mutations, and 70% to permit data sharing. A substantial minority believed that research using stored biospecimens should only proceed with specific consent.
Conclusion: When debates arise over appropriate use of archived biospecimens, the interests of the research participants in seeing productive use of their blood or tissue should be considered, in addition to addressing concerns about potential risks and lack of specific consent.
Implications for practice: This survey evaluated views of patients with cancer regarding the permissible use of stored biospecimens from cancer trials when modern scientific methods are not well described in the original informed consent document. The vast majority of patients support translational research and expect that any biospecimens they donate will be used to advance knowledge. When researchers, policy makers, and those charged with research oversight debate use of stored biospecimens, it is important to recognize that research participants have an interest in productive use of their blood, tissue, or data, in addition to considerations of risks and the adequacy of documented consent.
Keywords: Biobank; Cancer trials; Informed consent; Patient survey; Research ethics.
© AlphaMed Press 2019.
Conflict of interest statement
Figures
Similar articles
-
Secondary Use of Patient Tissue in Cancer Biobanks.Oncologist. 2019 Dec;24(12):1577-1583. doi: 10.1634/theoncologist.2018-0376. Epub 2019 Jun 10. Oncologist. 2019. PMID: 31182655 Free PMC article.
-
Parental attitudes and willingness to donate children's biospecimens for congenital heart disease research: a cross-sectional study in Shanghai, China.BMJ Open. 2018 Oct 17;8(10):e022290. doi: 10.1136/bmjopen-2018-022290. BMJ Open. 2018. PMID: 30337311 Free PMC article.
-
Willingness to Donate Remnant Human Biospecimens in the Context of the COVID-19 Pandemic.Biopreserv Biobank. 2022 Apr;20(2):123-131. doi: 10.1089/bio.2021.0036. Epub 2021 Jul 16. Biopreserv Biobank. 2022. PMID: 34271844
-
Research participants' perceptions and views on consent for biobank research: a review of empirical data and ethical analysis.BMC Med Ethics. 2015 Sep 9;16:60. doi: 10.1186/s12910-015-0053-5. BMC Med Ethics. 2015. PMID: 26354520 Free PMC article. Review.
-
Ethical considerations for biobanking and use of genomics data in Africa: a narrative review.BMC Med Ethics. 2023 Dec 5;24(1):108. doi: 10.1186/s12910-023-00985-y. BMC Med Ethics. 2023. PMID: 38053109 Free PMC article. Review.
Cited by
-
"My Research Is Their Business, but I'm Not Their Business": Patient and Clinician Perspectives on Commercialization of Precision Oncology Data.Oncologist. 2020 Jul;25(7):620-626. doi: 10.1634/theoncologist.2019-0863. Epub 2020 Mar 13. Oncologist. 2020. PMID: 32167617 Free PMC article.
-
Perception of Polish patients with cancer of the ethical and legal issues related to biobank research.Oncologist. 2024 Jul 5;29(7):e887-e898. doi: 10.1093/oncolo/oyae078. Oncologist. 2024. PMID: 38666716 Free PMC article.
-
Building a Decentralized Biobanking App for Research Transparency and Patient Engagement: Participatory Design Study.JMIR Hum Factors. 2025 Mar 5;12:e59485. doi: 10.2196/59485. JMIR Hum Factors. 2025. PMID: 40053747 Free PMC article.
-
Patients' and Members of the Public's Wishes Regarding Transparency in the Context of Secondary Use of Health Data: Scoping Review.J Med Internet Res. 2023 Apr 13;25:e45002. doi: 10.2196/45002. J Med Internet Res. 2023. PMID: 37052967 Free PMC article.
-
Health data sharing attitudes towards primary and secondary use of data: a systematic review.EClinicalMedicine. 2024 Mar 18;71:102551. doi: 10.1016/j.eclinm.2024.102551. eCollection 2024 May. EClinicalMedicine. 2024. PMID: 38533128 Free PMC article.
References
-
- Vaught J, Rogers J, Myers K et al. An NCI perspective on creating sustainable biospecimen resources. J Natl Cancer Inst Monogr 2011;2011:1–7. - PubMed
-
- Strech D, Bein S, Brumhard M et al. A template for broad consent in biobank research. Results and explanation of an evidence and consensus‐based development process. Eur J Med Genet 2016;59:295–309. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources